Gary Morrow
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Radiation Oncology |
|---|
| Address | University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 704
Rochester NY 14642
|
|---|
|
|
|
| Title | Professor |
|---|
| Institution | University of Rochester Medical Center |
|---|
| Department | Cancer Center |
|---|
|
|
|---|
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Psychiatry |
|---|
| Division | Psychiatry - Behav/Psychosoc Med |
|---|
|
|---|
|
|
|
|
| American Cancer Society Scientific Advisory Committee on Institutional Research Grants, 1991; | |
|
|
| Vice Chairman, 1993; Chairman, 1994 | |
|
|
| Evan and Marion Helfaer Distinguished Lectureship, Medical College of Wisconsin, 1989 | |
|
|
| New York State Governors Commission on Cancer Control, 1989-present | |
|
|
| Irene Lefton Leukemia Foundation Lectureship, November, 1988 | |
|
|
| Board of Scientific Counselors, Illinois Cancer Council, 1987 | |
|
|
| Research Career Development Award, 1985-90 | |
|
|
| American Cancer Society Council on Research and Investigative Awards, 1984-1989 | |
|
|
| Who's Who in the Biobehavioral Science, 1983 | |
|
|
| Who's Who in Frontier Science and Technology, 1983 | |
|
|
| Fellow, American Psychological Association, Division 38 (Health Psychology), 1983 | |
|
|
| Academy of Behavioral Medicine Research, 1982 | |
|
|
| American Cancer Society Scientific Advisory Committee on Clinical Investigations: | |
|
|
| Psychosocial and Behavioral Research, 1980-1984; Chairman, 1983-84 | |
|
|
| American Cancer Society Scientific Advisory Committee on Prevention, Diagnosis and Therapy, 1978-80 | |
|
|
| NDEA Fellowship, 1974-75 | |
|
|
| Dean's Award (outstanding technical article of the year), Notre Dame, 1967 | |
|
|
| Pi Tau Sigma (National Mechanical Engineering Honorary), Notre Dame, Chapter President, 1966-67 | |
|
|
| Tau Kappa Alpha (National Forensic Honorary), Notre Dame, Chapter President, 1966-67 | |
|
|
| Sophomore Engineer of the Year, Notre Dame, 1965 | |
|
|
| Naval ROTC Scholarship, 1963-67 | |
|
|
| Distinguished Paper Award, MAPSS, Temple University, 1961 |
-
Janelsins MC, Tejani MA, Kamen C, Peoples AR, Mustian KM, Morrow GR. Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients. Expert Opin Pharmacother. 2013 Apr; 14(6):757-66.
-
Gewandter JS, Fan L, Magnuson A, Mustian K, Peppone L, Heckler C, Hopkins J, Tejani M, Morrow GR, Mohile SG. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013 Jul; 21(7):2059-66.
-
Lavigne JE, Heckler C, Mathews JL, Palesh O, Kirshner JJ, Lord R, Jacobs A, Amos E, Morrow GR, Mustian K. A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors. Breast Cancer Res Treat. 2012 Nov; 136(2):479-86.
-
Roscoe JA, Heckler CE, Morrow GR, Mohile SG, Dakhil SR, Wade JL, Kuebler JP. Prevention of delayed nausea: a university of Rochester cancer center community clinical oncology program study of patients receiving chemotherapy. J Clin Oncol. 2012 Sep 20; 30(27):3389-95.
-
Palesh OG, Mustian KM, Peppone LJ, Janelsins M, Sprod LK, Kesler S, Innominato PF, Roth T, Manber R, Heckler C, Fiscella K, Morrow GR. Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: A trial from the University of Rochester Cancer Center Community Clinical Oncology Program. Sleep Med. 2012 Oct; 13(9):1184-90.
-
Chandwani KD, Ryan JL, Peppone LJ, Janelsins MM, Sprod LK, Devine K, Trevino L, Gewandter J, Morrow GR, Mustian KM. Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med. 2012; 2012:979213.
-
Kirshner JJ, Heckler CE, Janelsins MC, Dakhil SR, Hopkins JO, Coles C, Morrow GR. Prevention of Pegfilgrastim-Induced Bone Pain: A Phase III Double-Blind Placebo-Controlled Randomized Clinical Trial of the University of Rochester Cancer Center Clinical Community Oncology Program Research Base. J Clin Oncol. 2012 Jun 1; 30(16):1974-9.
-
Purnell JQ, Peppone LJ, Alcaraz K, McQueen A, Guido JJ, Carroll JK, Shacham E, Morrow GR. Perceived discrimination, psychological distress, and current smoking status: results from the behavioral risk factor surveillance system reactions to race module, 2004-2008. Am J Public Health. 2012 May; 102(5):844-51.
-
Sprod LK, Janelsins MC, Palesh OG, Carroll JK, Heckler CE, Peppone LJ, Mohile SG, Morrow GR, Mustian KM. Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan. J Cancer Surviv. 2012 Jun; 6(2):146-54.
-
Peppone LJ, Mustian KM, Morrow GR, Dozier AM, Ossip DJ, Janelsins MC, Sprod LK, McIntosh S. The effect of cigarette smoking on cancer treatment-related side effects. Oncologist. 2011; 16(12):1784-92.
-
Ryan JL, Heckler CE, Roscoe JA, Dakhil SR, Kirshner J, Flynn PJ, Hickok JT, Morrow GR. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer. 2012 Jul; 20(7):1479-89.
-
Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol. 2011 Jun; 38(3):431-8.
-
Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, Sprod LK, Heckler CE, Roscoe JA, Katz AW, Williams JP, Morrow GR. Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer. 2012 Apr; 20(4):831-9.
-
Janelsins MC, Davis PG, Wideman L, Katula JA, Sprod LK, Peppone LJ, Palesh OG, Heckler CE, Williams JP, Morrow GR, Mustian KM. Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer. 2011 Jun; 11(3):161-70.
-
Mohile SG, Fan L, Reeve E, Jean-Pierre P, Mustian K, Peppone L, Janelsins M, Morrow G, Hall W, Dale W. Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol. 2011 Apr 10; 29(11):1458-64.
-
Peppone LJ, Huston AJ, Reid ME, Rosier RN, Zakharia Y, Trump DL, Mustian KM, Janelsins MC, Purnell JQ, Morrow GR. The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Res Treat. 2011 May; 127(1):171-7.
-
Mustian KM, Roscoe JA, Palesh OG, Sprod LK, Heckler CE, Peppone LJ, Usuki KY, Ling MN, Brasacchio RA, Morrow GR. Polarity Therapy for cancer-related fatigue in patients with breast cancer receiving radiation therapy: a randomized controlled pilot study. Integr Cancer Ther. 2011 Mar; 10(1):27-37.
-
Roscoe JA, Morrow GR, Aapro MS, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer. 2011 Oct; 19(10):1533-8.
-
Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, Peppone L, Hemstad A, Esparaz BT, Hopkins JO. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer. 2010 Jul 15; 116(14):3513-20.
-
Peppone LJ, Mustian KM, Janelsins MC, Palesh OG, Rosier RN, Piazza KM, Purnell JQ, Darling TV, Morrow GR. Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial. Clin Breast Cancer. 2010 Jun; 10(3):224-9.
-
Janelsins MC, Roscoe JA, Berg MJ, Thompson BD, Gallagher MJ, Morrow GR, Heckler CE, Jean-Pierre P, Opanashuk LA, Gross RA. IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest. 2010 Jun; 28(5):544-53.
-
Morrow GR, Hesketh PJ, Schwartzberg LS, Ettinger DS. Recent Advances in the Management of Chemotherapy-induced Nausea and Vomiting: A Case Study Compendium. Clin Adv Hematol Oncol. 2010 May; 8(5 Suppl 9):1-16.
-
Purnell JQ, Palesh OG, Heckler CE, Adams MJ, Chin N, Mohile S, Peppone LJ, Atkins JN, Moore DF, Spiegel D, Messing E, Morrow GR. Racial disparities in traumatic stress in prostate cancer patients: secondary analysis of a National URCC CCOP Study of 317 men. Support Care Cancer. 2011 Jul; 19(7):899-907.
-
Peppone LJ, Reid ME, Moysich KB, Morrow GR, Jean-Pierre P, Mohile SG, Darling TV, Hyland A. The effect of secondhand smoke exposure on the association between active cigarette smoking and colorectal cancer. Cancer Causes Control. 2010 Aug; 21(8):1247-55.
-
Peppone LJ, Hebl S, Purnell JQ, Reid ME, Rosier RN, Mustian KM, Palesh OG, Huston AJ, Ling MN, Morrow GR. The efficacy of calcitriol therapy in the management of bone loss and fractures: a qualitative review. Osteoporos Int. 2010 Jul; 21(7):1133-49.
-
Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010 Jan 10; 28(2):292-8.
-
Mustian KM, Peppone L, Darling TV, Palesh O, Heckler CE, Morrow GR. A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol. 2009 Sep-Oct; 7(5):158-67.
-
Roscoe JA, Morrow GR, Colagiuri B, Heckler CE, Pudlo BD, Colman L, Hoelzer K, Jacobs A. Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer. 2010 Jul; 18(7):869-76.
-
Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, Mustian KM, Morrow GR. Examining the association between cigarette smoking and colorectal cancer using historical case-control data. Cancer Epidemiol. 2009 Oct; 33(3-4):182-8.
-
Mohile SG, Xian Y, Dale W, Fisher SG, Rodin M, Morrow GR, Neugut A, Hall W. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009 Sep 2; 101(17):1206-15.
-
Kohli S, Fisher SG, Tra Y, Adams MJ, Mapstone ME, Wesnes KA, Roscoe JA, Morrow GR. The effect of modafinil on cognitive function in breast cancer survivors. Cancer. 2009 Jun 15; 115(12):2605-16.
-
Dalton EJ, Rasmussen VN, Classen CC, Grumann M, Palesh OG, Zarcone J, Kraemer HC, Kirshner JJ, Colman LK, Morrow GR, Spiegel D. Sexual Adjustment and Body Image Scale (SABIS): a new measure for breast cancer patients. Breast J. 2009 May-Jun; 15(3):287-90.
-
Roscoe JA, Bushunow P, Jean-Pierre P, Heckler CE, Purnell JQ, Peppone LJ, Chen Y, Ling MN, Morrow GR. Acupressure bands are effective in reducing radiation therapy-related nausea. J Pain Symptom Manage. 2009 Sep; 38(3):381-9.
-
Peppone LJ, Piazza KM, Mahoney MC, Morrow GR, Mustian KM, Palesh OG, Hyland A. Associations between adult and childhood secondhand smoke exposures and fecundity and fetal loss among women who visited a cancer hospital. Tob Control. 2009 Apr; 18(2):115-20.
-
Colagiuri B, Roscoe JA, Morrow GR, Atkins JN, Giguere JK, Colman LK. How do patient expectancies, quality of life, and postchemotherapy nausea interrelate? Cancer. 2008 Aug 1; 113(3):654-61.
-
Classen CC, Kraemer HC, Blasey C, Giese-Davis J, Koopman C, Palesh OG, Atkinson A, Dimiceli S, Stonisch-Riggs G, Westendorp J, Morrow GR, Spiegel D. Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psychooncology. 2008 May; 17(5):438-47.
-
Carroll JK, Fiscella K, Epstein RM, Jean-Pierre P, Figueroa-Moseley C, Williams GC, Mustian KM, Morrow GR. Getting patients to exercise more: a systematic review of underserved populations. J Fam Pract. 2008 Mar; 57(3):170-6, E1-3, 1 p following E3.
-
Carroll JK, Fiscella K, Meldrum SC, Williams GC, Sciamanna CN, Jean-Pierre P, Morrow GR, Epstein RM. Clinician-patient communication about physical activity in an underserved population. J Am Board Fam Med. 2008 Mar-Apr; 21(2):118-27.
-
Shelke AR, Roscoe JA, Morrow GR, Colman LK, Banerjee TK, Kirshner JJ. Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage. 2008 Apr; 35(4):381-7.
-
Hawkins NA, Pollack LA, Leadbetter S, Steele WR, Carroll J, Dolan JG, Ryan EP, Ryan JL, Morrow GR. Informational needs of patients and perceived adequacy of information available before and after treatment of cancer. J Psychosoc Oncol. 2008; 26(2):1-16.
-
Sloan JA, Berk L, Roscoe J, Fisch MJ, Shaw EG, Wyatt G, Morrow GR, Dueck AC. Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol. 2007 Nov 10; 25(32):5070-7.
-
Hickok JT, Roscoe JA, Morrow GR, Ryan JL. A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study. Support Cancer Ther. 2007 Sep 1; 4(4):247-50.
-
Kim Y, Morrow GR. The effects of family support, anxiety, and post-treatment nausea on the development of anticipatory nausea: a latent growth model. J Pain Symptom Manage. 2007 Sep; 34(3):265-76.
-
Ryan JL, Bole C, Hickok JT, Figueroa-Moseley C, Colman L, Khanna RC, Pentland AP, Morrow GR. Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations. Br J Cancer. 2007 Jul 2; 97(1):14-21.
-
Kohli S, Griggs JJ, Roscoe JA, Jean-Pierre P, Bole C, Mustian KM, Hill R, Smith K, Gross H, Morrow GR. Self-reported cognitive impairment in patients with cancer. J Oncol Pract. 2007 Mar; 3(2):54-9.
-
Figueroa-Moseley C, Jean-Pierre P, Roscoe JA, Ryan JL, Kohli S, Palesh OG, Ryan EP, Carroll J, Morrow GR. Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw. 2007 Jan; 5(1):44-50.
-
Morrow GR. Cancer-related fatigue: causes, consequences, and management. Oncologist. 2007; 12 Suppl 1:1-3.
-
Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007; 12 Suppl 1:4-10.
-
Carroll JK, Kohli S, Mustian KM, Roscoe JA, Morrow GR. Pharmacologic treatment of cancer-related fatigue. Oncologist. 2007; 12 Suppl 1:43-51.
-
Roscoe JA, Kaufman ME, Matteson-Rusby SE, Palesh OG, Ryan JL, Kohli S, Perlis ML, Morrow GR. Cancer-related fatigue and sleep disorders. Oncologist. 2007; 12 Suppl 1:35-42.
-
Jean-Pierre P, Figueroa-Moseley CD, Kohli S, Fiscella K, Palesh OG, Morrow GR. Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist. 2007; 12 Suppl 1:11-21.
-
Mustian KM, Morrow GR, Carroll JK, Figueroa-Moseley CD, Jean-Pierre P, Williams GC. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist. 2007; 12 Suppl 1:52-67.
-
Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007; 12 Suppl 1:22-34.
-
Jean-Pierre P, Mustian K, Kohli S, Roscoe JA, Hickok JT, Morrow GR. Community-based clinical oncology research trials for cancer-related fatigue. J Support Oncol. 2006 Nov-Dec; 4(10):511-6.
-
Kim Y, Hickok JT, Morrow G. Fatigue and depression in cancer patients undergoing chemotherapy: an emotion approach. J Pain Symptom Manage. 2006 Oct; 32(4):311-21.
-
Reuter K, Classen CC, Roscoe JA, Morrow GR, Kirshner JJ, Rosenbluth R, Flynn PJ, Shedlock K, Spiegel D. Association of coping style, pain, age and depression with fatigue in women with primary breast cancer. Psychooncology. 2006 Sep; 15(9):772-9.
-
Okunieff P, Xu J, Hu D, Liu W, Zhang L, Morrow G, Pentland A, Ryan JL, Ding I. Curcumin protects against radiation-induced acute and chronic cutaneous toxicity in mice and decreases mRNA expression of inflammatory and fibrogenic cytokines. Int J Radiat Oncol Biol Phys. 2006 Jul 1; 65(3):890-8.
-
American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006 Jun 20; 24(18):2932-47.
-
Mallinger JB, Shields CG, Griggs JJ, Roscoe JA, Morrow GR, Rosenbluth RJ, Lord RS, Gross H. Stability of decisional role preference over the course of cancer therapy. Psychooncology. 2006 Apr; 15(4):297-305.
-
Roscoe JA, Jean-Pierre P, Shelke AR, Kaufman ME, Bole C, Morrow GR. The role of patients' response expectancies in side effect development and control. Curr Probl Cancer. 2006 Mar-Apr; 30(2):40-98.
-
Mustian KM, Griggs JJ, Morrow GR, McTiernan A, Roscoe JA, Bole CW, Atkins JN, Issell BF. Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study. Support Care Cancer. 2006 Jul; 14(7):732-41.
-
Liu W, Ding I, Chen K, Olschowka J, Xu J, Hu D, Morrow GR, Okunieff P. Interleukin 1beta (IL1B) signaling is a critical component of radiation-induced skin fibrosis. Radiat Res. 2006 Feb; 165(2):181-91.
-
Roscoe JA, Jean-Pierre P, Morrow GR, Hickok JT, Issell B, Wade JL, King DK. Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected. J Soc Integr Oncol. 2006; 4(1):16-20.
-
Hickok JT, Morrow GR, Roscoe JA, Mustian K, Okunieff P. Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage. 2005 Nov; 30(5):433-42.
-
Hickok JT, Roscoe JA, Morrow GR, Mustian K, Okunieff P, Bole CW. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer. 2005 Oct 15; 104(8):1772-8.
-
Hickok JT, Roscoe JA, Morrow GR, Bole CW, Zhao H, Hoelzer KL, Dakhil SR, Moore T, Fitch TR. 5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol. 2005 Oct; 6(10):765-72.
-
Pandya KJ, Morrow GR, Roscoe JA, Zhao H, Hickok JT, Pajon E, Sweeney TJ, Banerjee TK, Flynn PJ. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005 Sep 3-9; 366(9488):818-24.
-
Roscoe JA, Matteson SE, Morrow GR, Hickok JT, Bushunow P, Griggs J, Qazi R, Smith B, Kramer Z, Smith J. Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer. J Pain Symptom Manage. 2005 Apr; 29(4):376-84.
-
Han WT, Collie K, Koopman C, Azarow J, Classen C, Morrow GR, Michel B, Brennan-O'Neill E, Spiegel D. Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology. 2005 Apr; 14(4):318-30.
-
Roscoe JA, Matteson SE, Mustian KM, Padmanaban D, Morrow GR. Treatment of radiotherapy-induced fatigue through a nonpharmacological approach. Integr Cancer Ther. 2005 Mar; 4(1):8-13.
-
Yates JS, Mustian KM, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, Issell B, Kirshner JJ, Colman LK. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005 Oct; 13(10):806-11.
-
Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Griggs JJ, Matteson SE, Bushunow P, Qazi R, Smith B. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005 Feb; 89(3):243-9.
-
Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K. Management of cancer-related fatigue. Cancer Invest. 2005; 23(3):229-39.
-
Roscoe JA, Bushunow P, Morrow GR, Hickok JT, Kuebler PJ, Jacobs A, Banerjee TK. Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer. 2004 Dec 1; 101(11):2701-8.
-
Roscoe JA, Morrow GR, Hickok JT, Mustian KM, Shelke AR. Biobehavioral factors in chemotherapy-induced nausea and vomiting. J Natl Compr Canc Netw. 2004 Sep; 2(5):501-8.
-
Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, Wade JL, Fitch TR. Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices. Cancer. 2004 Aug 15; 101(4):851-7.
-
Shelke AR, Mustian KM, Morrow GR. The pathophysiology of treatment-related nausea and vomiting in cancer patients: current models. Indian J Physiol Pharmacol. 2004 Jul; 48(3):256-68.
-
Shields CG, Morrow GR, Griggs J, Mallinger J, Roscoe J, Wade JL, Dakhil SR, Fitch TR. Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program. Support Cancer Ther. 2004 Jan 1; 1(2):119-26.
-
Pandya KJ, Thummala AR, Griggs JJ, Rosenblatt JD, Sahasrabudhe DM, Guttuso TJ, Morrow GR, Roscoe JA. Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat. 2004 Jan; 83(1):87-9.
-
Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PL, Flynn PJ, Hynes HE, Banerjee TK, Kirshner JJ, King DK. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003 Dec 15; 21(24):4635-41.
-
Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Pierce HI, Flynn PJ, Kirshner JJ, Moore DF, Atkins JN. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage. 2003 Aug; 26(2):731-42.
-
Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer. 2003 Jun 1; 97(11):2880-6.
-
Kim Y, Morrow GR. Changes in family relationships affect the development of chemotherapy-related nausea symptoms. Support Care Cancer. 2003 Mar; 11(3):171-7.
-
Koopman C, Butler LD, Classen C, Giese-Davis J, Morrow GR, Westendorf J, Banerjee T, Spiegel D. Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress. 2002 Aug; 15(4):277-87.
-
Morrow GR, Hickok JT, Andrews PL, Stern RM. Reduction in serum cortisol after platinum based chemotherapy for cancer: a role for the HPA axis in treatment-related nausea? Psychophysiology. 2002 Jul; 39(4):491-5.
-
Roscoe JA, Morrow GR, Bushunow P, Tian L, Matteson S. Acustimulation wristbands for the relief of chemotherapy-induced nausea. Altern Ther Health Med. 2002 Jul-Aug; 8(4):56-7, 59-63.
-
Kim Y, Roscoe JA, Morrow GR. The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer. Support Care Cancer. 2002 Jul; 10(5):416-21.
-
Matteson S, Roscoe J, Hickok J, Morrow GR. The role of behavioral conditioning in the development of nausea. Am J Obstet Gynecol. 2002 May; 186(5 Suppl Understanding):S239-43.
-
Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PL. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer. 2002 May; 10(4):329-36.
-
Hickok JT, Roscoe JA, Morrow GR. The role of patients' expectations in the development of anticipatory nausea related to chemotherapy for cancer. J Pain Symptom Manage. 2001 Oct; 22(4):843-50.
-
Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S. Fatigue associated with cancer and its treatment. Support Care Cancer. 2002 Jul; 10(5):389-98.
-
Morrow GR, Roscoe JA, Hickok JT, Andrews PR, Matteson S. Nausea and emesis: evidence for a biobehavioral perspective. Support Care Cancer. 2002 Mar; 10(2):96-105.
-
Gianaros PJ, Stern RM, Morrow GR, Hickok JT. Relationship of gastric myoelectrical and cardiac parasympathetic activity to chemotherapy-induced nausea. J Psychosom Res. 2001 May; 50(5):263-6.
-
Roscoe JA, Morrow GR, Hickok JT, Stern RM. Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage. 2000 Aug; 20(2):113-21.
-
Pandya KJ, Raubertas RF, Flynn PJ, Hynes HE, Rosenbluth RJ, Kirshner JJ, Pierce HI, Dragalin V, Morrow GR. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med. 2000 May 16; 132(10):788-93.
-
Morrow GR, Andrews PL, Hickok JT, Stern R. Vagal changes following cancer chemotherapy: implications for the development of nausea. Psychophysiology. 2000 May; 37(3):378-84.
-
Roscoe JA, Hickok JT, Morrow GR. Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med. 2000; 22(2):121-6.
-
Nair MG, Hickok JT, Roscoe JA, Morrow GR. Sources of information used by patients to learn about chemotherapy side effects. J Cancer Educ. 2000; 15(1):19-22.
-
Spiegel D, Morrow GR, Classen C, Raubertas R, Stott PB, Mudaliar N, Pierce HI, Flynn PJ, Heard L, Riggs G. Group psychotherapy for recently diagnosed breast cancer patients: a multicenter feasibility study. Psychooncology. 1999 Nov-Dec; 8(6):482-93.
-
Morrow GR, Hickok JT, DuBeshter B, Lipshultz SE. Changes in clinical measures of autonomic nervous system function related to cancer chemotherapy-induced nausea. J Auton Nerv Syst. 1999 Oct 8; 78(1):57-63.
-
Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol. 1999 Sep; 17(9):2971-94.
-
Hickok JT, Roscoe JA, Morrow GR, Stern RM, Yang B, Flynn PJ, Hynes HE, Kirshner JJ, Rosenbluth RJ. Use of 5-HT3 receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings. Cancer. 1999 Jul 1; 86(1):64-71.
-
Morrow GR, Ballatori E, Groshen S, Olver I. Statistical considerations in the design, conduct and analyses of antiemetic clinical trials. An emerging consensus. Support Care Cancer. 1998 May; 6(3):261-5.
-
Morrow GR, Roscoe JA, Kirshner JJ, Hynes HE, Rosenbluth RJ. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics. Support Care Cancer. 1998 May; 6(3):244-7.
-
Morrow GR, Roscoe JA, Hickok JT, Stern RM, Pierce HI, King DB, Banerjee TK, Weiden P. Initial control of chemotherapy-induced nausea and vomiting in patient quality of life. Oncology (Williston Park). 1998 Mar; 12(3 Suppl 4):32-7.
-
Morrow GR, Roscoe JA, Hynes HE, Flynn PJ, Pierce HI, Burish T. Progress in reducing anticipatory nausea and vomiting: a study of community practice. Support Care Cancer. 1998 Jan; 6(1):46-50.
-
Muth ER, Morrow GR, Jiang W, Stern RM, Dubeshter B. Cardiac spectral power reflects parasympathetic but not sympathetic nervous system activity in a clinical population. J Auton Nerv Syst. 1996 Nov 6; 61(2):201-3.
-
Morrow GR, Rosenthal SN. Models, mechanisms and management of anticipatory nausea and emesis. Oncology. 1996 Jun; 53 Suppl 1:4-7.
-
Hickok JT, Morrow GR, McDonald S, Bellg AJ. Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: implications for management. J Pain Symptom Manage. 1996 Jun; 11(6):370-7.
-
Morrow GR, Hickok JT, Burish TG, Rosenthal SN. Frequency and clinical implications of delayed nausea and delayed emesis. Am J Clin Oncol. 1996 Apr; 19(2):199-203.
-
Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban). Cancer. 1995 Aug 1; 76(3):343-57.
-
Bellg AJ, Morrow GR, Barry M, Angel C, DuBeshter B. Autonomic measures associated with chemotherapy-related nausea: techniques and issues. Cancer Invest. 1995; 13(3):313-23.
-
Morrow GR, Hickok JT, Burish TG. Behavioral aspects of clinical trials. An integrated framework from behavior theory. Cancer. 1994 Nov 1; 74(9 Suppl):2676-82.
-
Morrow GR, Bellg AJ. Behavioral science in translational research and cancer control. Cancer. 1994 Aug 15; 74(4 Suppl):1409-17.
-
Morrow GR, Hickok JT. Behavioral treatment of chemotherapy-induced nausea and vomiting. Oncology (Williston Park). 1993 Dec; 7(12):83-9; discussion 93-4, 97.
-
Morrow GR. Behavioural factors influencing the development and expression of chemotherapy induced side effects. Br J Cancer Suppl. 1992 Dec; 19:S54-60; discussion S60-3.
-
Morrow GR. Methodology and assessment in clinical anti-emetic research: a meta-analysis of outcome parameters. Br J Cancer Suppl. 1992 Dec; 19:S38-41.
-
Morrow GR. A patient report measure for the quantification of chemotherapy induced nausea and emesis: psychometric properties of the Morrow assessment of nausea and emesis (MANE). Br J Cancer Suppl. 1992 Dec; 19:S72-4.
-
Morrow GR, Angel C, Dubeshter B. Autonomic changes during cancer chemotherapy induced nausea and emesis. Br J Cancer Suppl. 1992 Dec; 19:S42-5.
-
Morrow GR, Lindke J, Black P. Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC). Qual Life Res. 1992 Oct; 1(5):287-96.
-
Morrow GR, Asbury R, Hammon S, Dobkin P, Caruso L, Pandya K, Rosenthal S. Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists. Health Psychol. 1992; 11(4):250-6.
-
Holland JC, Morrow GR, Schmale A, Derogatis L, Stefanek M, Berenson S, Carpenter PJ, Breitbart W, Feldstein M. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol. 1991 Jun; 9(6):1004-11.
-
Morrow GR, Lindke J, Black PM. Predicting development of anticipatory nausea in cancer patients: prospective examination of eight clinical characteristics. J Pain Symptom Manage. 1991 May; 6(4):215-23.
-
Morrow GR, Lindke J, Black PM. Anticipatory nausea development in cancer patients: replication and extension of a learning model. Br J Psychol. 1991 Feb; 82 ( Pt 1):61-72.
-
Morrow GR, Black PM, Dudgeon DJ. Advances in data assessment. Application to the etiology of nausea reported during chemotherapy, concerns about significance testing, and opportunities in clinical trials. Cancer. 1991 Feb 1; 67(3 Suppl):780-7.
-
Morrow GR. Chemotherapy-related nausea and vomiting: etiology and management. CA Cancer J Clin. 1989 Mar-Apr; 39(2):89-104.
-
Morrow GR. Chemotherapy side effects and cancer patient nutrition. Nutrition. 1989 Mar-Apr; 5(2):119-21.
-
Mortola JF, Rasmussen DD, Yen SS. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism. J Clin Endocrinol Metab. 1989 Mar; 68(3):517-22.
-
Morrow GR. Anticipatory nausea. Cancer Invest. 1988; 6(3):327-8.
-
Morrow GR, Dobkin PL. Behavioral approaches for the management of adversive side effects of cancer treatment. Psychiatr Med. 1987; 5(4):299-314.
-
Poe RH, Wahl GW, Qazi R, Kallay MC, Utell MJ, Morrow GR. Predictors of mortality in the immunocompromised patient with pulmonary infiltrates. Arch Intern Med. 1986 Jul; 146(7):1304-8.
-
Dobkin PL, Morrow GR. Biopsychosocial assessment of cancer patients: methods and suggestions. Hosp J. 1986; 2(3):37-59.
-
Jaeger H, Morrow GR, Carpenter PJ, Brescia F. A survey of psychotropic drug utilization by patients with advanced neoplastic disease. Gen Hosp Psychiatry. 1985 Oct; 7(4):353-60.
-
Morrow GR. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer. 1985 Jun 15; 55(12):2766-70.
-
Morrow GR. Appropriateness of taped versus live relaxation in the systematic desensitization of anticipatory nausea and vomiting in cancer patients. J Consult Clin Psychol. 1984 Dec; 52(6):1098-9.
-
Morrow GR. Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. J Clin Oncol. 1984 Oct; 2(10):1170-6.
-
Morrow GR, Carpenter PJ, Hoagland AC. The role of social support in parental adjustment to pediatric cancer. J Pediatr Psychol. 1984 Sep; 9(3):317-29.
-
Morrow GR. Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy. Cancer Treat Rep. 1984 Sep; 68(9):1177-8.
-
Penman DT, Holland JC, Bahna GF, Morrow G, Schmale AH, Derogatis LR, Carnrike CL, Cherry R. Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol. 1984 Jul; 2(7):849-55.
-
Morrow GR. Methodology in behavioral and psychosocial cancer research. The assessment of nausea and vomiting. Past problems, current issues and suggestions for future research. Cancer. 1984 May 15; 53(10 Suppl):2267-80.
-
Morrow GR. Susceptibility to motion sickness and chemotherapy-induced side-effects. Lancet. 1984 Feb 18; 1(8373):390-1.
-
Schmale AH, Morrow GR, Schmitt MH, Adler LM, Enelow A, Murawski BJ, Gates C. Well-being of cancer survivors. Psychosom Med. 1983 May; 45(2):163-9.
-
Hoagland AC, Morrow GR, Bennett JM, Carnrike CL. Oncologists' views of cancer patient noncompliance. Am J Clin Oncol. 1983 Apr; 6(2):239-44.
-
Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CL. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983 Feb 11; 249(6):751-7.
-
Morrow GR, Bennett JM, Carpenter PJ. Informed consent to treatment in clinical trials. Biomed Pharmacother. 1983; 37(1):10-3.
-
Morrow GR, Morrell C. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy. N Engl J Med. 1982 Dec 9; 307(24):1476-80.
-
Levy SM, Morrow GR. Workshop report. Biobehavioral interventions in behavioral medicine. Cancer. 1982 Nov 1; 50(9 Suppl):1936-8.
-
Morrow GR, Way J, Hoagland AC, Cooper R. Patient compliance with self-directed Hemoccult testing. Prev Med. 1982 Sep; 11(5):512-20.
-
Morrow GR. Prevalence and correlates of anticipatory nausea and vomiting in chemotherapy patients. J Natl Cancer Inst. 1982 Apr; 68(4):585-8.
-
Morrow GR, Arseneau JC, Asbury RF, Bennett JM, Boros L. Anticipatory nausea and vomiting with chemotherapy. N Engl J Med. 1982 Feb 18; 306(7):431-2.
-
Schmale AH, Morrow GR, Davis A, Illies E, McNally J, Wright G, Craytor JK. Pretreatment behavioral profiles associated with subsequent psychosocial adjustment in radiation therapy patients: a prospective study. Int J Psychiatry Med. 1982; 12(3):187-95.
-
Morrow GR, Hoagland AC, Morse IP. Sources of support perceived by parents of children with cancer: implications for counselling. Patient Couns Health Educ. 1982; 4(1):36-40.
-
Morrow GR, Hoagland A, Carnrike CL. Social support and parental adjustment to pediatric cancer. J Consult Clin Psychol. 1981 Oct; 49(5):763-5.
-
Morrow GR, Feldstein M, Adler LM, Derogatis LR, Enelow AJ, Gates C, Holland J, Melisaratos N, Murawski BJ, Penman D, Schmale A, Schmitt M, Morse I. Development of brief measures of psychological adjustment to medical illness applied to cancer patients. Gen Hosp Psychiatry. 1981 Jun; 3(2):79-88.
-
Carpenter PJ, Morrow GR, Del Gaudio AC, Ritzler BA. Who keeps the first outpatient appointment? Am J Psychiatry. 1981 Jan; 138(1):102-5.
-
Morrow GR. How readable are subject consent forms? JAMA. 1980 Jul 4; 244(1):56-8.
-
McCusker J, Morrow GR. Factors related to the use of cancer early detection techniques. Prev Med. 1980 May; 9(3):388-97.
-
Morrow GR. Clinical trials in psychosocial medicine: methodologic and statistical considerations. Part III. Assessing measurement techniques in psychosocial oncology. Cancer Treat Rep. 1980 Feb-Mar; 64(2-3):451-6.
-
Derogatis LR, Feldstein M, Morrow G, Schmale A, Schmitt M, Gates C, Murawski B, Holland J, Penman D, Melisaratos N, Enelow AJ, Adler LM. A survey of psychotropic drug prescriptions in an oncology population. Cancer. 1979 Nov; 44(5):1919-29.
-
Novack DH, Plumer R, Smith RL, Ochitill H, Morrow GR, Bennett JM. Changes in physicians' attitudes toward telling the cancer patient. JAMA. 1979 Mar 2; 241(9):897-900.
-
Carpenter PJ, Del Gaudio AC, Morrow GR. Dropouts and terminators from a community mental health center: their use of other psyciatric services. Psychiatr Q. 1979; 51(4):271-9.
-
Del Gaudio AC, Carpenter PJ, Morrow GR. Male and female treatment differences: can they be generalized? J Consult Clin Psychol. 1978 Dec; 46(6):1577-8.
-
Morrow GR, Chiarello RJ, Derogatis LR. A new scale for assessing patients' psychosocial adjustment to medical illness. Psychol Med. 1978 Nov; 8(4):605-10.
-
Craytor JK, Brown JK, Morrow GR. Assessing learning needs of nurses who care for persons with cancer. Cancer Nurs. 1978 Jun; 1(3):211-20.
-
Morrow GR, Labrum A. The relationship between psychological and physiological measures of anxiety. Psychol Med. 1978 Feb; 8(1):95-101.
-
Morrow GR, Del Gaudio AC, Carpenter PJ. The dropout and the terminator: a methodological note on definitions. J Clin Psychol. 1977 Jul; 33(3):867-9.
-
Morrow GR, Craytor JK, Brown J, Fass M. Nurses' perceptions of themselves, cancer nurses, typical, ideal and cancer patients. Percept Mot Skills. 1976 Dec; 43(3 Pt 2):1083-91.
-
Barness LA, Morrow G. Methylmalonic aciduria. A newly discovered inborn error. Ann Intern Med. 1968 Sep; 69(3):633-5.
-
Morrow G, Kivirikko KI, Prockop DJ. Catabolism and excretion of free hydroxyproline in infancy. J Clin Endocrinol Metab. 1967 Oct; 27(10):1365-71.
-
Morrow G, Kivitikko KI, Prockop DJ. Hydroxyprolinemia and increased excretion of free hydroxyproline in early infancy. J Clin Endocrinol Metab. 1966 Sep; 26(9):1012-4.
|
Morrow's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
